Superstring Capital Management Lp Top Holdings and 13F Report (2026)

About Superstring Capital Management Lp

Investment Activity

Superstring Capital Management Lp has $139.97 million in total holdings as of March 31, 2026.
Superstring Capital Management Lp owns shares of 35 different stocks, but just 18 companies or ETFs make up 80% of its holdings.
Approximately 59.01% of the portfolio was purchased this quarter.
About 91.42% of the portfolio was sold this quarter.
This quarter, Superstring Capital Management Lp has purchased 45 new stocks and bought additional shares in 8 stocks.
Superstring Capital Management Lp sold shares of 11 stocks and completely divested from 25 stocks this quarter.

Largest Holdings

Summit Therapeutics: $16,928,872
Immunovant: $8,882,933
Cogent Biosciences: $8,666,331
Savara: $8,659,434
Urogen Pharma: $6,964,931

Largest New Holdings this Quarter

86627T108 - Summit Therapeutics: $16,928,872 Holding
24477V105 - DEFINIUM THERAPEUTICS INC: $6,642,613 Holding
92764N102 - Vir Biotechnology: $6,545,710 Holding
92243G108 - Vaxcyte: $6,418,482 Holding
92532F100 - Vertex Pharmaceuticals: $4,916,405 Holding

Largest Purchases this Quarter

Summit Therapeutics: 892,873 shares (about $16.93M)
DEFINIUM THERAPEUTICS INC: 351,461 shares (about $6.64M)
Vir Biotechnology: 730,548 shares (about $6.55M)
Vaxcyte: 110,454 shares (about $6.42M)
Vertex Pharmaceuticals: 11,010 shares (about $4.92M)

Largest Sales this Quarter

Urogen Pharma: 330,983 shares (about $5.95M)
Cogent Biosciences: 141,080 shares (about $5.43M)
Axsome Therapeutics: 26,216 shares (about $4.43M)
Taysha Gene Therapies: 722,499 shares (about $3.23M)
Cabaletta Bio: 1,187,311 shares (about $3.19M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
SMMT Summit Therapeutics	$16,928,872	$16,928,872 â–²	New Holding	892,873	12.1%	Medical
IMVT Immunovant	$8,882,933	$1,712,196 â–²	23.9%	357,606	6.3%	Medical
COGT Cogent Biosciences	$8,666,331	$5,430,169 â–¼	-38.5%	225,158	6.2%	Medical
SVRA Savara	$8,659,434	$3,224,807 â–²	59.3%	1,585,977	6.2%	Medical
URGN Urogen Pharma	$6,964,931	$5,951,075 â–¼	-46.1%	387,371	5.0%	Medical
DEFINIUM THERAPEUTICS INC	$6,642,613	$6,642,613 â–²	New Holding	351,461	4.7%	COM SHS
VIR Vir Biotechnology	$6,545,710	$6,545,710 â–²	New Holding	730,548	4.7%	Medical
PCVX Vaxcyte	$6,418,482	$6,418,482 â–²	New Holding	110,454	4.6%	Medical
CLDX Celldex Therapeutics	$5,711,123	$2,909,993 â–²	103.9%	180,048	4.1%	Medical
SIONNA THERAPEUTICS INC	$5,653,652	$1,586,321 â–¼	-21.9%	141,024	4.0%	COM
GMAB Genmab A/S	$5,277,702	$4,495,286 â–²	574.5%	196,709	3.8%	Medical
ZLAB Zai Lab	$5,188,137	$1,485,332 â–²	40.1%	275,818	3.7%	Medical
VRTX Vertex Pharmaceuticals	$4,916,405	$4,916,405 â–²	New Holding	11,010	3.5%	Medical
IQV IQVIA	$4,377,421	$4,377,421 â–²	New Holding	25,668	3.1%	Medical
MAPLIGHT THERAPEUTICS INC	$3,906,186	$3,906,186 â–²	New Holding	192,139	2.8%	COM
ARVN Arvinas	$3,313,772	$3,313,772 â–²	New Holding	312,620	2.4%	Medical
ORUKA THERAPEUTICS INC	$3,119,139	$3,119,139 â–²	New Holding	63,591	2.2%	COM
UTHR United Therapeutics	$3,075,194	$2,529,059 â–¼	-45.1%	5,186	2.2%	Medical
TVTX Travere Therapeutics	$3,052,821	$1,923,188 â–²	170.2%	102,754	2.2%	Medical
TRVI Trevi Therapeutics	$3,001,182	$1,232,059 â–²	69.6%	251,566	2.1%	Medical
ADLAI NORTYE LTD	$2,870,776	$2,870,776 â–²	New Holding	414,852	2.1%	SPONSORED ADS
CABA Cabaletta Bio	$2,868,183	$3,193,867 â–¼	-52.7%	1,066,239	2.0%	Medical
PFE Pfizer	$2,077,920	$2,077,920 â–²	New Holding	74,000	1.5%	Medical
AXSM Axsome Therapeutics	$1,895,897	$4,431,028 â–¼	-70.0%	11,217	1.4%	Medical
ORIC Oric Pharmaceuticals	$1,460,015	$1,775,523 â–¼	-54.9%	115,234	1.0%	Medical
ACRS Aclaris Therapeutics	$1,374,338	$1,374,338 â–²	New Holding	366,490	1.0%	Medical
ELYM Eliem Therapeutics	$1,364,582	$1,364,582 â–²	New Holding	199,209	1.0%	Medical
TSHA Taysha Gene Therapies	$1,154,462	$3,229,569 â–¼	-73.7%	258,269	0.8%	Medical
BRIGHT MINDS BIOSCIENCES INC	$971,304	$2,478,573 â–¼	-71.8%	13,311	0.7%	COM NEW
TONIX PHARMACEUTICALS HLDG C	$873,675	$873,675 â–²	New Holding	63,540	0.6%	COM NEW
CGEM Cullinan Therapeutics	$845,268	$845,268 â–²	New Holding	59,484	0.6%	Medical
TARA Protara Therapeutics	$632,791	$1,242,809 â–¼	-66.3%	121,457	0.5%	Medical
PALATIN TECHNOLOGIES INC	$626,580	$34,805 â–²	5.9%	35,969	0.4%	COM NEW
BMEA Biomea Fusion	$382,500		0.0%	250,000	0.3%	Medical
IPSC Century Therapeutics	$269,636	$776,660 â–¼	-74.2%	119,308	0.2%	Medical
CIDARA THERAPEUTICS INC	$0	$18,797,297 â–¼	-100.0%	0	0.0%	COM NEW
TERN Terns Pharmaceuticals	$0	$17,928,591 â–¼	-100.0%	0	0.0%	Medical
DVAX Dynavax Technologies	$0	$8,083,605 â–¼	-100.0%	0	0.0%	Medical
MNMD Mind Medicine (MindMed)	$0	$5,693,455 â–¼	-100.0%	0	0.0%	Medical
OCUL Ocular Therapeutix	$0	$5,075,491 â–¼	-100.0%	0	0.0%	Medical
FOLD Amicus Therapeutics	$0	$5,025,239 â–¼	-100.0%	0	0.0%	Medical
RVMD Revolution Medicines	$0	$4,371,112 â–¼	-100.0%	0	0.0%	Medical
BLTE Belite Bio	$0	$3,951,492 â–¼	-100.0%	0	0.0%	Medical
ZENAS BIOPHARMA INC	$0	$3,026,547 â–¼	-100.0%	0	0.0%	COM
QNCX Quince Therapeutics	$0	$2,876,682 â–¼	-100.0%	0	0.0%	Medical
AVALO THERAPEUTICS INC	$0	$2,784,164 â–¼	-100.0%	0	0.0%	COM NEW
CAPR Capricor Therapeutics	$0	$2,780,199 â–¼	-100.0%	0	0.0%	Medical
PALVELLA THERAPEUTICS INC NE	$0	$2,665,840 â–¼	-100.0%	0	0.0%	COM
ASSEMBLY BIOSCIENCES INC	$0	$2,219,935 â–¼	-100.0%	0	0.0%	COM NEW
TYRA Tyra Biosciences	$0	$1,542,618 â–¼	-100.0%	0	0.0%	Medical
VRDN Viridian Therapeutics	$0	$1,345,318 â–¼	-100.0%	0	0.0%	Medical
RZLT Rezolute	$0	$1,212,485 â–¼	-100.0%	0	0.0%	Medical
DIANTHUS THERAPEUTICS INC	$0	$1,081,721 â–¼	-100.0%	0	0.0%	COM
SPRUCE BIOSCIENCES INC	$0	$1,057,254 â–¼	-100.0%	0	0.0%	COM NEW
AARDVARK THERAPEUTICS INC	$0	$912,135 â–¼	-100.0%	0	0.0%	COM
PALISADE BIO INC	$0	$862,692 â–¼	-100.0%	0	0.0%	COM
FULC Fulcrum Therapeutics	$0	$814,999 â–¼	-100.0%	0	0.0%	Medical
RARE Ultragenyx Pharmaceutical	$0	$729,974 â–¼	-100.0%	0	0.0%	Medical
IVA Inventiva	$0	$465,000 â–¼	-100.0%	0	0.0%	Medical
ENTX Entera Bio	$0	$33,255 â–¼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Superstring Capital Management Lp Top Holdings and 13F Report (2026)

About Superstring Capital Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Superstring Capital Management Lp Top Holdings and 13F Report (2026)

About Superstring Capital Management Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofSuperstring Capital Management Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools